SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-029714
Filing Date
2024-06-11
Accepted
2024-06-11 16:28:10
Documents
15
Period of Report
2024-06-07
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20030506x2_8k.htm   iXBRL 8-K 32679
2 EXHIBIT 3.1 ny20030506x2_ex3-1.htm EX-3.1 5288
3 EXHIBIT 3.2 ny20030506x2_ex3-2.htm EX-3.2 15657
  Complete submission text file 0001140361-24-029714.txt   203756

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nexi-20240607.xsd EX-101.SCH 3868
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20240607_lab.xml EX-101.LAB 23415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20240607_pre.xml EX-101.PRE 17062
19 EXTRACTED XBRL INSTANCE DOCUMENT ny20030506x2_8k_htm.xml XML 4378
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 241036165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)